Expression of receptor for advanced glycation end products (RAGE) in human biliary cancer cells

Kenro Hirata1, Moriatsu Takada, Yasuyuki Suzuki

  • 1Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kobe University, 7-5-2, Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan.

Hepato-Gastroenterology
|October 24, 2003
PubMed
Abstract

Insights

Receptor for advanced glycation end products (RAGE) expression correlates with biliary cancer cell invasion. Targeting RAGE may offer a strategy to control tumor cell migration and metastasis in biliary cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Amphoterin, interacting with the receptor for advanced glycation end products (RAGE), regulates tumor cell invasion and migration.
  • RAGE is a cell surface molecule belonging to the immunoglobulin superfamily.

Purpose of the Study:

  • To investigate the role of RAGE in the invasion potential of human biliary cancer cells.
  • To determine the correlation between RAGE expression levels and the invasive capabilities of biliary cancer cell lines.

Main Methods:

  • Utilized three human biliary cancer cell lines: SK-ChA-1, TGBC-1, and NOZC-1.
  • Assessed cell invasion using the Matrigel invasion assay.
  • Quantified RAGE protein expression via Western blotting.

Main Results:

  • SK-ChA-1 and NOZC-1 cells exhibited high invasion potential (40.3 +/- 3.27 and 48.7 +/- 4.8, respectively).
  • TGBC-1 cells demonstrated low invasion potential (25.7 +/- 2.8).
  • Strong RAGE expression was observed in high-invasion SK-ChA-1 and NOZC-1 cells, while TGBC-1 cells showed faint RAGE expression.

Conclusions:

  • RAGE expression levels are consistent with the observed invasion abilities of human biliary cancer cells.
  • Modulating RAGE activity presents a potential therapeutic target for controlling biliary cancer invasion and metastasis.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...